Stéphanie Pascarella

482 total citations
13 papers, 356 citations indexed

About

Stéphanie Pascarella is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Stéphanie Pascarella has authored 13 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 6 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Stéphanie Pascarella's work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cancer Research and Treatments (2 papers). Stéphanie Pascarella is often cited by papers focused on Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cancer Research and Treatments (2 papers). Stéphanie Pascarella collaborates with scholars based in Switzerland, United States and Italy. Stéphanie Pascarella's co-authors include Francesco Negro, Sophie Clément, Kévin Guilloux, Carmen Gonelle‐Gispert, Michelangelo Foti, Lucie Bourgoin, Marion Peyrou, Laura Rubbia‐Brandt, Pierluigi Ramadori and Manlio Vinciguerra and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Stéphanie Pascarella

13 papers receiving 346 citations

Peers

Stéphanie Pascarella
Stéphanie Pascarella
Citations per year, relative to Stéphanie Pascarella Stéphanie Pascarella (= 1×) peers Daw‐Jen Tsuei

Countries citing papers authored by Stéphanie Pascarella

Since Specialization
Citations

This map shows the geographic impact of Stéphanie Pascarella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Pascarella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Pascarella more than expected).

Fields of papers citing papers by Stéphanie Pascarella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Pascarella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Pascarella. The network helps show where Stéphanie Pascarella may publish in the future.

Co-authorship network of co-authors of Stéphanie Pascarella

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Pascarella. A scholar is included among the top collaborators of Stéphanie Pascarella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Pascarella. Stéphanie Pascarella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sullivan, Ryan J., Oladapo Yeku, Deanna Teoh, et al.. (2025). First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer. The Oncologist. 30(6). 2 indexed citations
2.
Powderly, John D., Ryan J. Sullivan, Martin Gutierrez, et al.. (2023). Phase 1/2 study of mRNA-4359 administered alone and in combination with immune checkpoint blockade in adult participants with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). TPS2676–TPS2676. 14 indexed citations
4.
Morard, Isabelle, Sophie Clément, Alexandra Calmy, et al.. (2014). Clinical Significance of the CCR5delta32 Allele in Hepatitis C. PLoS ONE. 9(9). e106424–e106424. 8 indexed citations
5.
Pascarella, Stéphanie, Sophie Clément, Michael T. Dill, et al.. (2012). Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C. Liver International. 33(1). 94–103. 4 indexed citations
6.
Peyrou, Marion, Lucie Bourgoin, David M. Suter, et al.. (2011). 810 DOWNREGULATION OF PTEN AND IRS1 BY HCV 3A CORE PROTEIN TRIGGERS STEATOSIS IN HEPATOCYTES. Journal of Hepatology. 54. S325–S325. 1 indexed citations
7.
Pascarella, Stéphanie, et al.. (2011). Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: Comparison between different genotypes and core protein sequence analysis. Journal of Medical Virology. 83(6). 1005–1015. 20 indexed citations
8.
Clément, Sophie, Marion Peyrou, Lucie Bourgoin, et al.. (2011). Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets. Hepatology. 54(1). 38–49. 57 indexed citations
9.
Clément, Sophie, et al.. (2011). 773 HEPATITIS C VIRUS AND LIPID DROPLETS: ROLE OF SEIPIN IN LIPID DROPLET MATURATION AND VIRAL LIFE CYCLE. Journal of Hepatology. 54. S311–S311. 1 indexed citations
10.
Clément, Sophie, et al.. (2010). The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8. Journal of Hepatology. 52(5). 635–643. 53 indexed citations
11.
Pascarella, Stéphanie & Francesco Negro. (2010). Hepatitis D virus: an update. Liver International. 31(1). 7–21. 92 indexed citations
12.
Pazienza, Valerio, Sophie Clément, Paolo Pugnale, et al.. (2009). Gene expression profile of Huh‐7 cells expressing hepatitis C virus genotype 1b or 3a core proteins. Liver International. 29(5). 661–669. 26 indexed citations
13.
Clément, Sophie, Stéphanie Pascarella, & Francesco Negro. (2009). Hepatitis C Virus Infection: Molecular Pathways to Steatosis, Insulin Resistance and Oxidative Stress. Viruses. 1(2). 126–143. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026